Lobby groups dismissive of Pharmac’s medicines wait-list cull

+News

Lobby groups dismissive of Pharmac’s medicines wait-list cull

iceberg
While Pharmac wants to cull eight dormant drug funding applications, 100 more drugs languish waiting for approval, critics say
Pharmac’s proposed medicine funding overhaul is a PR stunt offering little action to address funding for medicines New Zealanders need, critics say. , Sarah Fitt, People want definitive funding decisions, even if a drug is declined, Pharmac chief executive Sarah Fitt says